The Ambassador of Cuba in Washington D.C., José Ramón Cabañas, paid a working visit to Florida on April 9- 10.
The high-ranking official had the opportunity to meet with businesspersons from several companies with contracts in Cuba, in particular, with those from the transportation sector, which in 2017, transported more than one million passengers to the Island from the United States.
The Cuban company Heber Biotec and the U.S. company Mercurio Biotec join efforts to bring Heberprot-P therapy to patients who suffer from diabetic foot ulcer (DFU) in the United States, upon approval from the U.S. Food and Drug Administration (FDA).
According to the press note released by the entrepreneurial group BioCubaFarma, the Cuban therapy is expected to lower in more than half the current figure of risk of diabetic foot ulcer-related amputations in the United States, due to the successful history of the product and the commitment given by Mercurio and Heber.
Delegations from Cuba and the United States met to establish a Plan for Bilateral Coordination as part of the implementation of an Agreement signed by both countries in the field of cooperation on the preparedness and response to the pollution caused by discharges of hydrocarbons and other harmful or potentially hazardous substances in the Gulf of Mexico and the Florida Straits.